Promising results in France with an ASF vaccine

Published 2023년 3월 29일

Tridge summary

The French Food Safety Agency (ANSES) has developed an attenuated strain of the African swine fever (ASF) virus, derived from the Georgia 2007/1 strain, which is circulating in the European Union. This new strain causes only mild symptoms in pigs, with a much higher survival rate compared to the original strain. The vaccine, which can be administered both intramuscularly and orally, is under further testing for safety and efficacy. It is not produced through genetic manipulation, which may facilitate its authorization for use in the natural environment, particularly for vaccinating wild boars in Western Europe. ANSES has filed a patent for the vaccine.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The French Food Safety Agency (ANSES), which is the reference laboratory in France for African swine fever (ASF), inactivated the Georgia 2007/1 viral strain, which is currently circulating in the European Union. During the control of the effects of this heat inactivation, an attenuated strain, derived from the Georgia strain, was detected. This strain only caused a mild fever in the infected animal, whereas infection with the Georgia strain is generally fatal in 100% of cases. The researchers carried out a series of studies on this attenuated strain and confirmed the weak symptoms in most of the pigs inoculated with this virus by the intramuscular or oronasal route. Although the safety was not perfect, the survival rate was much higher than with the original viral strain. Intramuscular vaccination is the most widely used method on farms, but oral vaccination could allow vaccinating wild boars by baiting. This method was used for classical swine fever in the early 2000s and made ...
Source: Agrodigital

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.